Ligand validation:7Z2Y

IHS: D-MYO-INOSITOL-HEXASULPHATE

IHS is a Ligand Of Interest in 7Z2Y designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7Z2Y_IHS_A_502	96%	53%	0.069	0.976	0.77	1.03	1	3	3	0	100%	0.963
7Z2Y_IHS_A_501	30%	8%	0.21	0.876	1.86	2.83	12	17	3	0	100%	1
7Z2W_IHS_A_501	98%	60%	0.063	0.986	0.62	0.91	-	1	2	0	100%	0.977
7Z2T_IHS_A_501	98%	60%	0.062	0.984	0.64	0.88	-	2	2	0	100%	0.997
7Z3V_IHS_A_501	45%	59%	0.205	0.939	0.67	0.88	-	1	3	0	100%	0.534
7Z2S_IHS_A_501	40%	51%	0.178	0.887	0.91	0.99	2	2	0	0	100%	0.647
4TSR_IHS_A_505	29%	21%	0.179	0.836	2.03	1.3	18	3	1	0	100%	0.77
4ARO_IHS_A_502	99%	28%	0.059	0.99	1.46	1.42	5	7	0	0	100%	1
7ZGH_IHS_A_501	96%	58%	0.071	0.98	0.73	0.89	1	1	1	0	100%	0.961
3K4Q_IHS_B_500	86%	15%	0.113	0.982	1.29	2.48	5	16	0	0	100%	0.77

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.